Join the Pravastatin group to help and get support from people like you.
Pravastatin News
Statin Use Linked to Reduced Mortality for Patients With Sepsis
THURSDAY, June 12, 2025 – For critically ill adults with sepsis, statin use is associated with reduced mortality, according to a study published online June 5 in Frontiers in Immunology. Caifeng Li,...
Statins Appear Effective In Treating Sepsis
TUESDAY, June 10, 2025 — Statins are a gold-standard treatment for lowering cholesterol, but a new study shows the inexpensive drugs could provide another life-saving service. Patients with sepsis a...
Two-Drug Combo of a Statin Plus Ezetimibe, Lowers Cholesterol Better Than Statins Alone
TUESDAY, March 25, 2025 – Statins are very cheap and highly effective cholesterol-lowering drugs – but high-risk heart patients may have an even better option, a new evidence review says. Combining...
FDA Medwatch Alert: FDA Requests Removal of Strongest Warning Against Using Cholesterol-Lowering Statins During Pregnancy; Still Advises Most Pregnant Patients Should Stop Taking Statins
What safety information is FDA announcing? The U.S. Food and Drug Administration (FDA) is requesting removal of its strongest warning against using cholesterol-lowering statin medicines in pregnant...
FDA Medwatch Alert: Pravastatin Sodium Tablets by International Laboratories: Recall - Mislabeling
ISSUE: International Laboratories, LLC is voluntarily recalling one (1) Lot of Pravastatin Sodium Tablets USP 40 mg packaged in bottles of 30 tablets, to the consumer level due to mislabeling. The...
FDA Medwatch Alert: Red Yeast Rice by Doctor’s Best: Recall - Undeclared Lovastatin
ISSUE: Doctor’s Best is voluntarily recalling lot 3121005 (7379 bottles) of Red Yeast Rice dietary supplement, 600 mg Capsules, 120-count bottles to the retail level. Doctor’s Best Red Yeast Rice has ...
FDA Medwatch Alert: Statins and HIV or Hepatitis C Drugs: Drug Safety Communication - Interaction Increases Risk of Muscle Injury
ISSUE: FDA notified healthcare professionals of updates to the prescribing information concerning interactions between protease inhibitors and certain statin drugs. Protease inhibitors and statins ...
FDA Medwatch Alert: Statin Drugs - Drug Safety Communication: Class Labeling Change
ISSUE: FDA has approved important safety label changes for the class of cholesterol-lowering drugs known as statins. The changes include removal of routine monitoring of liver enzymes from drug...
Further information
Related condition support groups
High Cholesterol, High Cholesterol - Familial Heterozygous